Literature DB >> 20484032

Telomere loss as a mechanism for chromosome instability in human cancer.

John P Murnane1.   

Abstract

Cancer cells commonly have a high rate of telomere loss, even when expressing telomerase, contributing to chromosome instability and tumor cell progression. This review addresses the hypothesis that this high rate of telomere loss results from a combination of four factors. The first factor is an increase in the frequency of double-strand breaks (DSB) at fragile sites in cancer cells due to replication stress. The second factor is that telomeres are fragile sites. The third factor is that subtelomeric regions are highly sensitive to DSBs, so that DSBs near telomeres have an increased probability of resulting in chromosome instability. The fourth factor is that cancer cells may be deficient in chromosome healing, the de novo addition of telomeres to the sites of DSBs, a mechanism that prevents chromosome instability resulting from DSBs near telomeres. Understanding these factors and how they influence telomere loss will provide important insights into the mechanisms of chromosome instability and the development of novel approaches for anti-cancer therapy. Cancer Res; 70(11); 4255-9. (c)2010 AACR. Copyright 2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20484032      PMCID: PMC2967490          DOI: 10.1158/0008-5472.CAN-09-4357

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Alternative lengthening of telomeres: dangerous road less travelled.

Authors:  Roger R Reddel; Tracy M Bryan
Journal:  Lancet       Date:  2003-05-31       Impact factor: 79.321

2.  Distance from the chromosome end determines the efficiency of double strand break repair in subtelomeres of haploid yeast.

Authors:  Miria Ricchetti; Bernard Dujon; Cécile Fairhead
Journal:  J Mol Biol       Date:  2003-05-09       Impact factor: 5.469

3.  DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line.

Authors:  Anthony W I Lo; Laure Sabatier; Bijan Fouladi; Géraldine Pottier; Michelle Ricoul; John P Murnane
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

4.  The relationship between spontaneous telomere loss and chromosome instability in a human tumor cell line.

Authors:  B Fouladi; L Sabatier; D Miller; G Pottier; J P Murnane
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

5.  Characterization of terminal deletions at 7q32 and 22q13.3 healed by De novo telomere addition.

Authors:  H Varley; S Di; S W Scherer; N J Royle
Journal:  Am J Hum Genet       Date:  2000-08-01       Impact factor: 11.025

6.  Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors.

Authors:  D Gisselsson; T Jonson; A Petersén; B Strömbeck; P Dal Cin; M Höglund; F Mitelman; F Mertens; N Mandahl
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

7.  Effect of telomere proximity on telomere position effect, chromosome healing, and sensitivity to DNA double-strand breaks in a human tumor cell line.

Authors:  Avanti Kulkarni; Oliver Zschenker; Gloria Reynolds; Douglas Miller; John P Murnane
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

Review 8.  Connecting chromosomes, crisis, and cancer.

Authors:  Richard S Maser; Ronald A DePinho
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

9.  DNA damage signalling prevents deleterious telomere addition at DNA breaks.

Authors:  Svetlana Makovets; Elizabeth H Blackburn
Journal:  Nat Cell Biol       Date:  2009-10-18       Impact factor: 28.824

10.  Chromosome instability as a result of double-strand breaks near telomeres in mouse embryonic stem cells.

Authors:  Anthony W I Lo; Carl N Sprung; Bijan Fouladi; Mehrdad Pedram; Laure Sabatier; Michelle Ricoul; Gloria E Reynolds; John P Murnane
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more
  42 in total

1.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

Review 2.  Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  World J Virol       Date:  2012-12-12

Review 3.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins.

Authors:  Paula Martínez; María A Blasco
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

4.  PIF1 disruption or NBS1 hypomorphism does not affect chromosome healing or fusion resulting from double-strand breaks near telomeres in murine embryonic stem cells.

Authors:  Gloria E Reynolds; Qing Gao; Douglas Miller; Bryan E Snow; Lea A Harrington; John P Murnane
Journal:  DNA Repair (Amst)       Date:  2011-09-25

Review 5.  Telomere dysfunction and chromosome instability.

Authors:  John P Murnane
Journal:  Mutat Res       Date:  2011-05-07       Impact factor: 2.433

6.  Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction.

Authors:  Despoina Sakellariou; Maria Chiourea; Christina Raftopoulou; Sarantis Gagos
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

7.  Parameters affecting telomere-mediated chromosomal truncation in Arabidopsis.

Authors:  Andrew D Nelson; Jonathan C Lamb; Pierre S Kobrossly; Dorothy E Shippen
Journal:  Plant Cell       Date:  2011-06-07       Impact factor: 11.277

Review 8.  Genetics of leukocyte telomere length and its role in atherosclerosis.

Authors:  Abraham Aviv
Journal:  Mutat Res       Date:  2011-05-08       Impact factor: 2.433

9.  Expression of Telomere Binding Proteins (RAP1 and POT1) in Renal Cell Carcinoma and Their Correlation with Clinicopathological Parameters.

Authors:  Deeksha Pal; Shrawan Kumar Singh; Nandita Kakkar; Rajendra Prasad
Journal:  Indian J Clin Biochem       Date:  2016-09-03

10.  ATM Inhibition Potentiates Death of Androgen Receptor-inactivated Prostate Cancer Cells with Telomere Dysfunction.

Authors:  Vidyavathi Reddy; Min Wu; Nicholas Ciavattone; Nathan McKenty; Mani Menon; Evelyn R Barrack; G Prem-Veer Reddy; Sahn-Ho Kim
Journal:  J Biol Chem       Date:  2015-09-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.